Wnt/β-catenin signaling, whose activation has been shown to be strongly involved in the development of glioma, in the maintenance of stem potential, invasiveness, angiogenesis, radio, and chemoresistance, is considered one of the best-known pathways mainly targeted by COX-2 inhibition in GBM [24,28]. Here, PTGS2 is linked to glioma.